Derivative Contracts (Tables)

9 Months Ended

Sep. 30, 2013

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of fair values and derivative financial instrument

The following table summarizes the fair values and the presentation of our derivative financial instruments in the Condensed Consolidated Balance Sheets:

(In thousands)	Balance Sheet Component	September 30, 2013		December 31, 2012
Derivative financial instruments:
Pharmsynthez Note Receivable and      Purchase Option	Prepaid expenses and other current assets	$	6,755	$	—
Neovasc common stock options/warrants	Investments, net	$	1,618	$	1,872
Embedded conversion option	3.00% convertible senior notes, net of discount      and estimated fair value of embedded      derivatives	$	99,823	$	—
Forward contracts (1)	Current portion of lines of credit and notes       payable	$	3,899	$	1,294

(1) The effect on loss in the forward contracts is recorded in Accrued expenses. The effect on income in the forward contracts is recorded in Prepaid expenses and other current assets.

Summary of loss (gain) recorded in Fair value changes of derivative financial instruments

The following table summarizes the (losses) and gains recorded during the three and nine months ended September 30, 2013 and 2012:

	Three months ended September 30,						Nine months ended September 30,
(In thousands)	2013			2012			2013			2012
Derivative gain (loss):
Pharmsynthez Note Receivable and Purchase Option	$	(147	)	$	—		$	2,452		$	—
Neovasc common stock options/warrants and BZNE Note      conversion feature	(545		)	201			700			1,368
Notes	(26,943		)	—			(41,818		)	—
Forward contracts	(158		)	(32		)	(25		)	(59		)
Total	$	(27,793	)	$	169		$	(38,691	)	$	1,309

Outstanding contracts recorded at fair value and their maturity details

The outstanding forward contracts at September 30, 2013 and December 31, 2012, have been recorded at fair value, and their maturity details are as follows:

(In thousands) Days until maturity	Contract value		Fair value at  September 30, 2013		Effect on income (loss)
0 to 30	$	1,133	$	1,139	$	6
31 to 60	1,058		1,039		(19		)
61 to 90	945		939		(6		)
91 to 120	272		271		(1		)
121 to 180	516		511		(5		)
More than 180	—		—		—
Total	$	3,924	$	3,899	$	(25	)

(In thousands) Days until maturity	Contract value		Fair value at  December 31, 2012		Effect on income (loss)
0 to 30	$	—	$	—	$	—
31 to 60	581		577		(4		)
61 to 90	341		339		(2		)
91 to 120	212		210		(2		)
121 to 180	170		168		(2		)
More than 180	—		—		—
Total	$	1,304	$	1,294	$	(10	)